Bridgewater Associates LP Sells 5,944 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Bridgewater Associates LP lessened its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 74.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,075 shares of the company's stock after selling 5,944 shares during the period. Bridgewater Associates LP's holdings in Addus HomeCare were worth $260,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Smartleaf Asset Management LLC increased its stake in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after purchasing an additional 214 shares during the period. Parkside Financial Bank & Trust increased its position in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. bought a new stake in Addus HomeCare during the 4th quarter valued at $77,000. Harvest Fund Management Co. Ltd bought a new stake in Addus HomeCare during the 4th quarter valued at $86,000. Finally, KBC Group NV grew its stake in shares of Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $1.04 on Friday, hitting $100.58. 97,408 shares of the company were exchanged, compared to its average volume of 162,977. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72. The firm has a market capitalization of $1.83 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The company's 50 day moving average price is $97.93 and its 200-day moving average price is $116.15.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million during the quarter, compared to analysts' expectations of $291.04 million. As a group, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ADUS. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Tuesday. Stephens reaffirmed an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Macquarie reissued an "outperform" rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $139.00.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.